Sutro Biopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 7.19 M | $24.87 M | -6.76% | 8.76% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 7.02 M | $24.28 M | 100.00% | 8.55% |
| VANGUARD GROUP INC | 11/13/2024 | 4.20 M | $14.51 M | 17.99% | 5.11% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 3.00 M | $10.37 M | -32.61% | 3.65% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 2.83 M | $9.80 M | -6.94% | 3.45% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 2.25 M | $7.79 M | 12.51% | 2.74% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 2.20 M | $7.60 M | 0.00% | 2.68% |
| CITADEL ADVISORS LLC | 11/14/2024 | 2.13 M | $7.36 M | 31.28% | 2.59% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2024 | 2.07 M | $7.15 M | 2.11% | 2.52% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 2.03 M | $7.03 M | -53.42% | 2.48% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.86 M | $6.43 M | 7.65% | 2.26% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 1.84 M | $6.37 M | 5.91% | 2.25% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.75 M | $6.04 M | 66.41% | 2.13% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 1.72 M | $5.94 M | -4.27% | 2.09% |
| STATE STREET CORP | 11/14/2024 | 1.65 M | $5.70 M | 5.23% | 2.01% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 1.61 M | $5.57 M | 2.22% | 1.96% |
| BAILLIE GIFFORD & CO | 11/05/2024 | 1.52 M | $5.26 M | -17.82% | 1.85% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 1.20 M | $4.15 M | 32.49% | 1.46% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 980,318 | $3.39 M | -9.67% | 1.19% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 828,097 | $2.87 M | 15.09% | 1.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 821,746 | $2.84 M | -21.75% | 1.00% |
| BANK OF MONTREAL /CAN/ | 11/13/2024 | 814,955 | $2.85 M | 100.00% | 0.99% |
| AQUILO CAPITAL MANAGEMENT, LLC | 11/14/2024 | 762,498 | $2.64 M | 0.00% | 0.93% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/14/2024 | 737,670 | $2.55 M | 5,299.82% | 0.90% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 590,900 | $2.04 M | -13.93% | 0.72% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 491,765 | $1.70 M | -2.35% | 0.60% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 437,051 | $1.51 M | 100.00% | 0.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 359,919 | $1.25 M | 100.00% | 0.44% |
| UBS OCONNOR LLC | 11/14/2024 | 338,222 | $1.17 M | 22.96% | 0.41% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 329,579 | $1.14 M | 0.00% | 0.40% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 325,538 | $1.13 M | 14.82% | 0.40% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 283,600 | $981,256 | -55.28% | 0.35% |
| MORGAN STANLEY | 11/14/2024 | 274,085 | $948,337 | -4.77% | 0.33% |
| BARCLAYS PLC | 11/19/2024 | 273,019 | $944,000 | 385.26% | 0.33% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2024 | 271,337 | $938,826 | 0.00% | 0.33% |
| LPL FINANCIAL LLC | 11/08/2024 | 269,899 | $933,851 | 17.27% | 0.33% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 251,995 | $871,903 | 16.22% | 0.31% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 244,809 | $847,039 | -73.02% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 215,049 | $744,070 | -21.15% | 0.26% |
| OMERS ADMINISTRATION CORP | 11/13/2024 | 190,300 | $658,438 | 100.00% | 0.23% |
| FMR LLC | 11/13/2024 | 189,041 | $654,082 | 24.91% | 0.23% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 182,226 | $630,502 | 0.45% | 0.22% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 167,645 | $580,052 | 30.30% | 0.20% |
| UBS GROUP AG | 11/14/2024 | 165,859 | $573,872 | 429.02% | 0.20% |
| MAN GROUP PLC | 11/14/2024 | 163,928 | $567,191 | 25.83% | 0.20% |
| STRS OHIO | 11/01/2024 | 152,800 | $528,688 | -7.56% | 0.19% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 151,221 | $523,225 | 17.93% | 0.18% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 129,152 | $446,866 | 35.25% | 0.16% |
| SHERBROOKE PARK ADVISERS LLC | 11/14/2024 | 128,850 | $445,821 | 575.56% | 0.16% |
| RHUMBLINE ADVISERS | 11/12/2024 | 119,378 | $413,038 | 2.82% | 0.15% |
Sutro Biopharma, Inc.institutional Ownership - FAQ's
During the previous two years, 146 institutional investors and hedge funds held shares of Sutro Biopharma, Inc.. The most heavily invested institutionals were:
Versant Capital Management, Inc: 0
SUVRETTA CAPITAL MANAGEMENT, LLC: 7.19 M
BlackRock Funding, Inc. /DE: 7.02 M
VANGUARD GROUP INC: 4.2 M
Point72 Asset Management, L.P.: 3 M
BioImpact Capital LLC: 2.83 M
76.20% of Sutro Biopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 69.25 M shares in the last 24 months. This purchase volume represents approximately $140.58 M in transactions.